Company intelligence / Profile preview

PhageGuard

Wageningen, Gelderland, Netherlandsphageguard.com ↗

Ownership: Private
Employees: ~23
Development stage: Commercial

Overview

PhageGuard has developed several FDA and USDA-approved phage-based solutions that specifically target major foodborne pathogens such as Listeria, Salmonella, and E. coli O157. Their products are validated through industry trials and academic collaborations, offering a natural alternative to chemical interventions without affecting beneficial bacteria or product quality. The company continues to expand its portfolio into animal health applications like Campylobacter reduction in poultry.

Therapeutic areas: OtherInfectious Diseases
Modalities: Bacteriophages (phages)
Industry: Non-Drug Biotech

Drug pipeline

3 assets

PhageGuard-E

Commercial

Indications: E. coli O157 contamination prevention in food

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with major global food producersresearch partnerships with ETH Zurich, Ghent Universitypartnership for Salmonella control in Canadian Poultry Industry

Beyond the preview

Go deeper on PhageGuard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhageGuard.

Explore the full profile